Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chaplen

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Biosensors & Bioelectronics|March 31, 2005
A low-cost, portable generic biotoxicity assay for environmental monitoring applicationsVivek Sharma, Arthi Narayanan, Thirumalai Rengachari, et al.
Journal of the Chemical Society. Perkin Transactions 1|January 1, 1975
Studies concerning the antibiotic actinonin. Part VIII. Structure-activity relationships in the actinonin seriesB J Broughton, P Chaplen, W A Freeman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2001
A phase II trial of bryostatin 1 in the treatment of metastatic colorectal cancerJ A Zonder, A F Shields, M Zalupski, et al.
American Journal of Clinical Oncology|February 11, 2003
Phase II study of paclitaxel and carboplatin in patients with advanced gastric cancerShirish M Gadgeel, Anthony F Shields, Lance K Heilbrun, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 17, 2002
Tumor necrosis factor-induced modulation of glyoxalase I activities through phosphorylation by PKA results in cell death and is accompanied by the formation of a specific methylglyoxal-derived AGEFranky Van Herreweghe, Jianqiang Mao, Frank W R Chaplen, et al.
Journal of Medicinal Chemistry|November 1, 1975
Antiallergic activity of 2-phenyl-8-azapurin-6-onesB J Broughton, P Chaplen, P Knowles, et al.
FEMS Microbiology Letters|February 13, 2015
Nitrobacter winogradskyi transcriptomic response to low and high ammonium concentrationsLuis Sayavedra-Soto, Rebecca Ferrell, Michael Dobie, et al.
Msystems|March 27, 2018
Genome-Scale, Constraint-Based Modeling of Nitrogen Oxide Fluxes during Coculture of <i>Nitrosomonas europaea</i> and <i>Nitrobacter winogradskyi</i>Brett L Mellbye, Andrew T Giguere, Ganti S Murthy, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2008
Phase II study of docetaxel and celecoxib, a cyclooxygenase-2 inhibitor, in elderly or poor performance status (PS2) patients with advanced non-small cell lung cancerShirish M Gadgeel, Antoinette Wozniak, John C Ruckdeschel, et al.
Cancer|August 16, 2001
Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinomaP A Philip, M M Zalupski, V K Vaitkevicius, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Biosensors & Bioelectronics|March 31, 2005
A low-cost, portable generic biotoxicity assay for environmental monitoring applicationsVivek Sharma, Arthi Narayanan, Thirumalai Rengachari, et al.
Journal of the Chemical Society. Perkin Transactions 1|January 1, 1975
Studies concerning the antibiotic actinonin. Part VIII. Structure-activity relationships in the actinonin seriesB J Broughton, P Chaplen, W A Freeman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2001
A phase II trial of bryostatin 1 in the treatment of metastatic colorectal cancerJ A Zonder, A F Shields, M Zalupski, et al.
American Journal of Clinical Oncology|February 11, 2003
Phase II study of paclitaxel and carboplatin in patients with advanced gastric cancerShirish M Gadgeel, Anthony F Shields, Lance K Heilbrun, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 17, 2002
Tumor necrosis factor-induced modulation of glyoxalase I activities through phosphorylation by PKA results in cell death and is accompanied by the formation of a specific methylglyoxal-derived AGEFranky Van Herreweghe, Jianqiang Mao, Frank W R Chaplen, et al.
Journal of Medicinal Chemistry|November 1, 1975
Antiallergic activity of 2-phenyl-8-azapurin-6-onesB J Broughton, P Chaplen, P Knowles, et al.
FEMS Microbiology Letters|February 13, 2015
Nitrobacter winogradskyi transcriptomic response to low and high ammonium concentrationsLuis Sayavedra-Soto, Rebecca Ferrell, Michael Dobie, et al.
Msystems|March 27, 2018
Genome-Scale, Constraint-Based Modeling of Nitrogen Oxide Fluxes during Coculture of <i>Nitrosomonas europaea</i> and <i>Nitrobacter winogradskyi</i>Brett L Mellbye, Andrew T Giguere, Ganti S Murthy, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 4, 2008
Phase II study of docetaxel and celecoxib, a cyclooxygenase-2 inhibitor, in elderly or poor performance status (PS2) patients with advanced non-small cell lung cancerShirish M Gadgeel, Antoinette Wozniak, John C Ruckdeschel, et al.
Cancer|August 16, 2001
Phase II study of gemcitabine and cisplatin in the treatment of patients with advanced pancreatic carcinomaP A Philip, M M Zalupski, V K Vaitkevicius, et al.
Pageof 4